Critical Success Factors for Maximizing Test Volume and Reimbursement
Molecular diagnostics leaders face persistent challenges in growing their laboratory’s market share.
Despite the complex nature of molecular diagnostics, ensuring the completion of tests and maximizing reimbursement of claims remains the best mechanism for increasing revenue.
Several important dynamics can play crucial roles in overcoming these challenges, including increasing physician and patient communication at the time of order, facilitating patient access to diagnostics and timely adherence, proactively setting expectations related to patient financial obligations, and maximizing efficient claims reimbursement with an effective appeals strategy.
This webinar will deliver practical approaches, process enhancements, and payor strategies essential to growing novel diagnostic market share through proactive, purposeful, and technologically enabled engagements with patients, physicians, and payors.
Physician engagement strategies and techniques used by diagnostic providers to increase ordering volumes, maximize clean claims, automate denials, and execute payor-specific appeals strategies to maximize reimbursement.How purpose-built revenue cycle management solutions are critical to increasing cash collections and work in tandem with EHRs that facilitate physician adoption and ordering of novel and esoteric testing.The most effective patient communication touchpoints and technology enablers to assist patients in preparing for out-of-pocket expenses and increase test completion rates.The specific types of business intelligence, data models, visualizations, and analytics that better inform your executives, financial, and sales teams.
Automation and process enhancement opportunities related to prior authorizations, insurance discovery, benefits determination, eligibility verification, front-end payor edits, exception processing, and denials and appeals management.
Chief Commercial Officer, XIFIN, Inc.
Harley Ross holds a cross-functional strategic role working with the executive leadership team to oversee XIFIN’s efforts associated with go-to-market strategy for new and existing markets as well as strategic product integration initiatives.
Sr. Director, MDx Support Services, XIFIN, Inc.
Clarisa Blattner has over 20 years of healthcare experience, with 18 years being in revenue cycle management within the lab industry for such organizations as US Labs, Clarient, and MDxHealth.